studies examining GH effects on IGF-1 without hypothalamic-adrenal axis confounding
doi: 10.1093/neuonc/noy148.069 233 ThomasPLMRStphaneOBernardEChristyRBJEet al
PIONEER 1 PIONEER 1 was a 26-week, multinational trial in which 703 patients (including 116 from Japan) with type 2 diabetes uncontrolled with diet and exercise were randomized to double-blind monotherapy with oral semaglutide 3, 7, or 14 mg, or placebo [45]
Enabling Safe, Scalable Chemistry As a global leader in specialty chemicals, Albemarle provides critical reagents used to manufacture small-molecule active pharmaceutical ingredients (APIs) that power next-generation GLP-1 treatments
Glutathione binds to the enzyme, hindering the metabolic pathway of melanin, preventing it from producing dark pigmented melanin or eumelanin, and will instead bring about light-pigmented melanin or phaeomelanin
Both are on the July 2026 Pharmacy Compounding Advisory Committee agenda for 503A compounding review, which is a separate regulatory question from approval